AI-Powered Glucose Tracking Market to Hit $12 Billion by 2033 - Life AI Weekly #69
May 27, 2026 -
Life AI Weekly
Hi there,
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we're spotlighting the projected growth of the AI glucose tracking app market, which is expected to reach $12 billion by 2033. This surge is largely attributed to the rising prevalence of diabetes and the increasing use of smartphones, highlighting the growing intersection of technology and health management.
In other news, The Deerborne Group is set to present their AI-driven COMPASS 360™ platform at the ASCO 2026 Annual Meeting, focusing on its application in oncology diagnostics. Meanwhile, Brain Navi Biotechnology has launched NaoTrac, an AI-powered neurosurgical robot designed to enhance precision and reduce invasiveness in brain surgeries. These stories, among others, underscore the transformative potential of AI technologies in improving healthcare outcomes and advancing medical research.
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we're spotlighting the projected growth of the AI glucose tracking app market, which is expected to reach $12 billion by 2033. This surge is largely attributed to the rising prevalence of diabetes and the increasing use of smartphones, highlighting the growing intersection of technology and health management.
In other news, The Deerborne Group is set to present their AI-driven COMPASS 360™ platform at the ASCO 2026 Annual Meeting, focusing on its application in oncology diagnostics. Meanwhile, Brain Navi Biotechnology has launched NaoTrac, an AI-powered neurosurgical robot designed to enhance precision and reduce invasiveness in brain surgeries. These stories, among others, underscore the transformative potential of AI technologies in improving healthcare outcomes and advancing medical research.
AI-Powered Glucose Tracking Market to Hit $12 Billion by 2033
The global market for glucose tracking apps, currently valued at $5 billion, is projected to grow to $12 billion by 2033, driven by factors such as increased diabetes prevalence and smartphone usage. Read more
bitBiome Secures Funding for AI Bio-Manufacturing
bitBiome, a biotechnology company, has raised over 45 million USD in a seed extension round to advance its AI-driven bio-manufacturing efforts. Read more
Octagos Launches Ask Atlas AI Tool for Clinics
Octagos has introduced Ask Atlas, an AI tool that allows cardiac device clinics to query their clinical, operational, and billing data using plain language. This aims to assist care teams in managing large data volumes and enhancing their understanding of remote monitoring data. Read more
Parkinson's Foundation Launches AI-Driven PD Trial Navigator
The Parkinson's Foundation has introduced the PD Trial Navigator, identifying over 2,000 potential participants for Neuron23's NEULARK clinical trial, enhancing recruitment for Parkinson's research. Read more
The Deerborne Group to Present AI Insights at ASCO 2026
The Deerborne Group will participate in the ASCO 2026 Annual Meeting, showcasing its AI-driven COMPASS 360™ platform and discussing its applications in oncology diagnostics. Read more
Brain Navi Launches AI-Driven Neurosurgery Robot
Brain Navi Biotechnology has introduced NaoTrac, a neurosurgical robot that uses AI for enhanced precision and reduced invasiveness in brain surgeries. Read more
Cornerstone Robotics Gains CE Mark for Sentire® System
The Sentire® Surgical System by Cornerstone Robotics has been approved for CE mark certification, allowing its entry into European markets for minimally invasive surgeries. Read more
ABILITY Neurotech Gets Approval for ALS BCI Trial
ABILITY Neurotech has received approval to begin a clinical trial in the Netherlands for its brain-computer interface in ALS patients, marking a shift to long-term investigation. Read more
HkeyBio Develops AI Validation Engine for Autoimmune Drug Discovery
HkeyBio has announced a new wet-lab validation engine to enhance AI-driven drug discovery for autoimmune diseases, aiming to improve molecule validation and translational efficiency. Read more
NeuroXT and BIDMC Expand AI Collaboration for Alzheimer's Treatment
NeuroXT and BIDMC have announced an expansion of their collaboration to enhance AI-driven precision treatment for Alzheimer's disease, building on their initial research success. Read more
b.well and myTomorrows Partner to Improve Clinical Trial Access
The partnership between b.well Connected Health and myTomorrows focuses on using AI to enhance patient access to clinical trials by integrating health data and technology. Read more
Tata Elxsi Introduces ViTel™ for Medical Tech
The Indian company Tata Elxsi has launched ViTel™, an AI solution designed to enhance healthcare delivery and patient outcomes using advanced analytics and machine learning. Read more
Insilico Medicine and Human Longevity Partner on AI for Longevity
Insilico Medicine and Human Longevity have announced a collaboration to develop AI models focused on human longevity science, aiming to enhance drug discovery and predictive healthcare. Read more
Neurophet and VHIR Collaborate on AI for MS Detection
Neurophet has partnered with VHIR to develop and validate AI algorithms for detecting multiple sclerosis using MRI data. The collaboration will enhance Neurophet's AQUA MS software, which is FDA-cleared. Read more
Merck and eschbach Present AI Innovations at Summit
At the Pharma Manufacturing World Summit, Merck and eschbach showcased their collaboration on the 'Intelligent Visual Factory', focusing on enhancing pharmaceutical manufacturing with AI-driven solutions. Read more
CDD Partners with Eli Lilly for AI Drug Discovery
Collaborative Drug Discovery has partnered with Eli Lilly to integrate Lilly TuneLab into CDD Vault, aiming to enhance drug discovery through AI and machine learning. Read more
Prezent Vivo and Nested Knowledge Partner for AI-Driven Intelligence
The partnership between Prezent Vivo and Nested Knowledge seeks to enhance competitive intelligence in life sciences by integrating AI with human expertise for faster preparation of medical congresses. Read more
Canvas Medical Launches AI-Powered Studio for EMR Workflows
Canvas Medical has launched Canvas Studio, a no-code tool that allows healthcare professionals to create custom EMR workflows without software engineering skills, using Claude Code and the Canvas SDK. Read more
Bristol Myers Squibb Partners with Anthropic for AI Platform
Bristol Myers Squibb has announced a strategic agreement with Anthropic to implement Claude Enterprise as a shared intelligence platform across its global operations, aiming to enhance medicine discovery and development. Read more
IGEL and Zscaler Launch AI-Driven Healthcare Security Blueprints
On May 20, 2026, IGEL and Zscaler announced new security blueprints to enhance distributed care delivery in healthcare. These blueprints focus on securing patient information and ensuring operational continuity across various healthcare settings. Read more
MemorialCare Offers AI Heart Disease Analysis with Cleerly
MemorialCare Heart & Vascular Institute has introduced Cleerly, an AI technology for heart disease analysis, becoming the first in Los Angeles County to do so. This system enhances coronary CT scans by measuring plaque in arteries to help prevent heart attacks. Read more
Hyro and Five9 Partner for Healthcare AI Integration
Hyro has partnered with Five9 to integrate healthcare-specific AI agents into Five9's contact center, reducing integration time to one hour. Read more
Vu Technologies and Moffitt Cancer Center Use AI for Tumor Visualization
In May 2026, Vu Technologies and Moffitt Cancer Center collaborated to enhance tumor visualization using AI and NVIDIA DGX Spark, aiming to improve cancer research. Read more
Outcomes4Me Acquires Geno.Me and Realyze Intelligence
Outcomes4Me has acquired Geno.Me and Realyze Intelligence to enhance its AI-driven cancer care services. This move is intended to improve patient access to personalized treatments and clinical trials. Read more
MGI Tech Unveils AI-Driven Lab Automation at SLAS 2026
MGI Tech Co., Ltd. presented its new laboratory automation and multi-omics solutions at SLAS 2026 in Vienna, Austria, including the PrepALL-pP8G, GenSIRO48, and VisiOmics (PMIF-20RS), aimed at improving research efficiency in life sciences. Read more
actAVA.ai's CHI-Bench Reveals AI Failures in Healthcare
AI company actAVA.ai has introduced CHI-Bench, a benchmark indicating that AI agents from Anthropic, OpenAI, and Google fail 72% of U.S. healthcare workflows. Read more
Canopy's AI Platform Reduces Hospitalizations in Oncology
At the 2026 ASCO Annual Meeting, Canopy revealed studies showing its Remote Therapeutic Monitoring Platform significantly reduces hospitalizations and costs for oncology patients. Read more
RADIN Health and AZmed Expand AI Radiology Capabilities
RADIN Health and AZmed have expanded their partnership, following FDA clearance for the Rayvolve® AI Suite's AZtrauma module, enhancing radiology workflow with new detection capabilities. Read more
The Path Raises $14.3 Million for AI Therapy
The Path, an AI therapy platform co-founded by Tony Robbins, has secured $14.3 million in seed funding led by Prime Movers Lab. The funds will be used to expand and scale the platform, which offers personalized AI therapy tools. Read more
Synakis Corp. Secures $2.6M for AI Ocular Therapies
Synakis Corp., a Toronto-based biotech firm, has raised CAD $2.6 million in pre-seed funding to advance its AI-driven ocular therapies, including SNK-125 for retinal detachment. Read more
Mabwell to Present AI-Enhanced ADC Data at 2026 ASCO Meeting
Mabwell will present clinical study results for its AI-enhanced ADC 9MW2821 at the 2026 ASCO Annual Meeting, showcasing promising data for advanced urothelial carcinoma and muscle-invasive bladder cancer. Read more
Verana Health Expands AI Bladder Cancer Database
Verana Health has expanded its AI-driven bladder cancer database to support research in genitourinary cancers, offering enhanced insights into disease detection and treatment outcomes. Read more
St. Luke's Launches Genomic Program to Improve Healthcare
The St. Luke's University Health Network has introduced the Helix Genomic Advantage program to integrate genomics into routine care, aiming to enhance health outcomes and reduce costs. Read more
Neurophet Appoints Dr. Tanenbaum as Scientific Advisor
Neurophet has appointed Dr. Lawrence N. Tanenbaum as its Scientific Advisor to enhance its AI imaging expertise. Dr. Tanenbaum's extensive experience in neuroradiology will support Neurophet in advancing its neuroimaging technologies and global collaborations. Read more
Leo Cancer Care's Marie® Gains CE Mark for Upright Radiotherapy
Leo Cancer Care has received CE marking for its Marie® upright radiotherapy system, enabling its commercial use across Europe. This system allows patients to undergo treatment in an upright position, aiming to improve comfort and efficiency. Read more
Caris Life Sciences to Present AI Oncology Studies at ASCO 2026
Caris Life Sciences will showcase 32 AI-driven studies on multi-omic biomarker research and real-world evidence at the 2026 ASCO Annual Meeting, covering various tumor types. Read more
Paragon Health Institute Proposes AI Safety Framework
The Paragon Health Institute has introduced a Digital Similarity Analysis framework to enhance the safety of AI-enabled medical devices by evaluating patient data similarity to training data. Read more
Sanyou Bio Launches AI Platform for Drug Discovery
Sanyou Bio has introduced Clicklinks, an AI-driven platform designed to enhance collaboration in drug discovery by connecting researchers, biotech companies, and universities. Read more
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
05/26
Brain Navi Introduces NaoTrac Surgical Robot for Precision Neurosurgery
05/26
Neurophet and VHIR Begin Joint Study on AI Imaging for Multiple Sclerosis
05/26
Insilico Medicine and Human Longevity Partner on AI Foundation Model for Longevity Science
05/26
Deerborne Group to Attend ASCO 2026 and Highlight AI Platform COMPASS 360
05/26
Parkinson's Foundation Identifies 2,000 Participants for Neuron23 Trial Through PD Trial Navigator
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
